Literature DB >> 22446632

Effect of needle length for response to hepatitis B vaccine in macrosomic neonates: a prospective randomized study.

Ramazan Ozdemir1, Fuat Emre Canpolat, Sadik Yurttutan, Mehmet Yekta Oncel, Omer Erdeve, Ugur Dilmen.   

Abstract

OBJECTIVES: The objective of this study was to determine whether use of a longer (1 in.) rather than a standard (5/8 in.) needle used for macrosomic neonates (birthweight over 4000 g) may affect antibody titers after immunization against hepatitis B virus (HBV).
METHODS: Fifty nine healthy infants were vaccinated at birth, 1, and 6 months of age with hepatitis B vaccine, with follow up to 7 months of age. Infants were randomized into two groups according to needle length of first vaccine at birth. First group vaccinated with standart needle length and other group received vaccine by longer needle length.
RESULTS: Macrosomic infants who were immunized with a longer needle achieved significantly higher antibody titers to hepatitis B surface antigen than standart needle length (median, 3890.2 vs 1311.7 mIU/mL, respectively; p=0.001).
CONCLUSIONS: Macrosomic neonates benefit from longer needle length with higher levels of antibody titers after HBV vaccination.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22446632     DOI: 10.1016/j.vaccine.2012.02.068

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

Review 1.  Effect of vaccine administration modality on immunogenicity and efficacy.

Authors:  Lu Zhang; Wei Wang; Shixia Wang
Journal:  Expert Rev Vaccines       Date:  2015-08-27       Impact factor: 5.217

Review 2.  The weight of obesity on the human immune response to vaccination.

Authors:  Scott D Painter; Inna G Ovsyannikova; Gregory A Poland
Journal:  Vaccine       Date:  2015-07-08       Impact factor: 3.641

3.  Needle size for vaccination procedures in children and adolescents.

Authors:  Paul V Beirne; Sarah Hennessy; Sharon L Cadogan; Frances Shiely; Tony Fitzgerald; Fiona MacLeod
Journal:  Cochrane Database Syst Rev       Date:  2018-08-09

4.  The SENIEUR protocol and the efficacy of hepatitis B vaccination in healthy elderly persons by age, gender, and vaccine route.

Authors:  Robert Edelman; Meagan E Deming; Franklin R Toapanta; Mark D Heuser; Lisa Chrisley; Robin S Barnes; Steven S Wasserman; William C Blackwelder; Barry S Handwerger; Marcela Pasetti; Khan M Siddiqui; Marcelo B Sztein
Journal:  Immun Ageing       Date:  2020-04-28       Impact factor: 6.400

5.  Body Mass Index and Antibody Persistence after Measles, Mumps, Rubella and Hepatitis B Vaccinations.

Authors:  Marco Fonzo; Annamaria Nicolli; Stefano Maso; Lorenzo Carrer; Andrea Trevisan; Chiara Bertoncello
Journal:  Vaccines (Basel)       Date:  2022-07-20

6.  A comparison of post vaccination hepatitis B surface antibody level on the large and appropriate for gestational age infants.

Authors:  Abdoulreza Esteghamati; Shirin Sayyahfar; Hossein Ghaemi; Mohammadamin Joulani; Yousef Moradi; Atefeh Talebi
Journal:  Clin Exp Vaccine Res       Date:  2021-01-31

7.  Rapid Weight Loss, Central Obesity Improvement and Blood Glucose Reduction Are Associated with a Stronger Adaptive Immune Response Following COVID-19 mRNA Vaccine.

Authors:  Mikiko Watanabe; Angela Balena; Davide Masi; Rossella Tozzi; Renata Risi; Alessandra Caputi; Rebecca Rossetti; Maria Elena Spoltore; Filippo Biagi; Emanuela Anastasi; Antonio Angeloni; Stefania Mariani; Carla Lubrano; Dario Tuccinardi; Lucio Gnessi
Journal:  Vaccines (Basel)       Date:  2022-01-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.